切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 437 -441. doi: 10.3877/cma.j.issn.2095-3224.2018.05.006

所属专题: 文献

论著

长非编码RNA H19在结直肠癌化疗敏感性中的作用研究
王秀梅1, 赵海平2,(), 秦琼3, 刘永强4, 张兵2, 武永胜2   
  1. 1. 010020 呼和浩特,内蒙古自治区肿瘤医院&内蒙古医科大学附属人民医院肿瘤内科
    2. 010020 呼和浩特,内蒙古自治区肿瘤医院&内蒙古医科大学附属人民医院腹外科
    3. 017000 内蒙古鄂尔多斯达拉特旗人民医院肿瘤内科
    4. 010059 呼和浩特,内蒙古医科大学附属医院腹外科
  • 收稿日期:2017-09-17 出版日期:2018-10-25
  • 通信作者: 赵海平
  • 基金资助:
    内蒙古自治区肿瘤医院院内基金(No.2017066)

Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer

Xiumei Wang1, Haiping Zhao2,(), Qiong Qin3, Yongqiang Liu4, Bing Zhang2, Yongsheng Wu2   

  1. 1. Department of oncology, Inner Mongolia Cancer Hospital & Department of oncology, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010020, China
    2. Department of General Surgery Inner Mongolia Cancer Hospital & Department of General Surgery, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010020, China
    3. Department of Oncology, Inner Mongolia Ordos Dalad Banner People′s Hospital, Inner Mongolia 017000, China
    4. Department of General Surgery, The Affiliated People′s Hospital of Inner Mongolia Medical University, Inner Mongolia 010059, China
  • Received:2017-09-17 Published:2018-10-25
  • Corresponding author: Haiping Zhao
  • About author:
    Corresponding author: Zhao Haiping, Email:
引用本文:

王秀梅, 赵海平, 秦琼, 刘永强, 张兵, 武永胜. 长非编码RNA H19在结直肠癌化疗敏感性中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(05): 437-441.

Xiumei Wang, Haiping Zhao, Qiong Qin, Yongqiang Liu, Bing Zhang, Yongsheng Wu. Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(05): 437-441.

目的

研究长非编码RNA H19在结直肠癌化疗药物敏感性中作用。

方法

分别构建lncRNA H19稳定过表达及表达沉默的结肠癌细胞株,分别加入5-FU培养,RT-qPCR检测H19表达,MTT法检测各组细胞增殖率,通过划痕实验检测各组迁移能力;Western blot检测各组细胞凋亡蛋白、耐药蛋白MDR1、MRP1和BCRP表达。

结果

与正常细胞比较,lncRNA H19在结直肠癌细胞中表达升高,lncRNA H19稳定过表达组细胞增殖率明显高于H19表达沉默组,lncRNA H19稳定过表达组细胞48 h迁移距离明显大于H19表达沉默组,lncRNA H19稳定过表达组Bax蛋白表达下调,BCL-2、MDR1、MRP1和BCRP表达上调,H19表达沉默组Bax蛋白表达上调,BCL-2、MDR1、MRP1和BCRP表达下调。

结论

lncRNA H19高表达的结直肠癌降低结直肠癌对化疗药物的敏感性,下调lncRNA H19表达可提高化疗药物的疗效。

Objective

To study the role of long non-coding RNA H19 in the chemosensitivity of colorectal cancer.

Methods

The colon cancer cell lines stably overexpressed and silenced with lncRNA H19 were constructed and cultured in 5-FU. The expression of H19 was detected by RT-qPCR. The cell proliferation rate was measured by MTT assay. The migration ability of each group was evaluated by scratch test. The protein expressions of MDR1, MRP1 and BCRP were detected by Western blot.

Results

Compared with normal cells, the expression of lncRNA H19 increased, and the proliferation rate of lncRNA H19 stable overexpression group was significantly higher than that of H19 silencing group. The migration distance in lncRNA H19 stable overexpression group was significantly longer than that in H19 silencing group and the overexpression of bcl-2 protein was down-regulated and bax、MDR1、MRP1 and BCRP was up-regulated in lncRNA H19 stable overexpression group. The expression of bcl-2 protein was up-regulated and the expression of bax、MDR1、MRP1 and BCRP was down-regulated in H19 silencing group.

Conclusion

Colorectal cancer with high expression of lncRNA H19 reduces the sensitivity of colorectal cancer to chemotherapeutic drugs, and down-regulation of lncRNA H19 expression can improve the curative effect of chemotherapy drugs.

图1 lncRNA H19在结直肠癌组织中高表达
图2 lncRNA H19转染
图3 结肠癌细胞株LoVo对5-FU的化疗敏感性
图4 各组细胞迁移水平
图5 蛋白表达印迹图
[1]
Siegel RL, Miller KD, Jemal A.Cancer statistics, 2015 [J]. CA Cancer J Clin,2016, 66(1):7-30
[2]
Song M, Garrett WS, Chan A. Nutrients, foods, and colorectal cancer prevention [J]. Gastroenterology, 2015, 148(6):1244-1260.
[3]
Boeckx N, Janssens K, Van Camp G, et al. The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review [J]. Crit Rev Oncol Hematol, 2018, 121:1-10.
[4]
Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[5]
Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[6]
Luo J, Qu J, Wu DK, et al. Long non-coding RNAs: a rising biotarget in colorectal cancer [J]. Oncotarget, 2017, 8(13):22187-22202.
[7]
Fanale D, Castiglia M1, Bazan V, et al. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer [J]. Adv Exp Med Biol, 2016, 937:207-228.
[8]
Collette J, Le Bourhis X, Adriaenssens E. Regulation of Human Breast Cancer by the Long Non-Coding RNA H19 [J]. Int J Mol Sci, 2017, 18(11). pii:E2319.
[9]
王胜杰,翟从劼,姜霞, 等. 结直肠癌相关长链非编码RNA的研究进展 [J]. 山东医药, 2017, 57(24):97-99.
[10]
黄东宁,梁小娜.长链非编码RNA在结直肠癌中的研究进展 [J]. 实用肿瘤学杂志, 2015, 29(3):263-266.
[11]
Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development [J]. DNA Repair (Amst), 2016, 45:25-33.
[12]
Cai X, Cullen BR.The imprinted H19 noncoding RNA is a primary microRNA precursor [J]. RNA.2007, 13(3):313-316.
[13]
Li H, Li J, Jia S, et al. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer [J]. Oncotarget, 2015, 6(31):31958-31984.
[14]
Tong M, Zheng W, Li H, et al. Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy [J]. Oncogenesis, 2016, 5(7):e242.
[15]
Li X, Cai H, Zheng W, et al. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups [J]. Oncotarget, 2016, 7(8):8743-8755.
[16]
Jo YK, Park NY, Shin JH, et al. Up-regulation of UVRAG by HDAC1 inhibition attenuates 5FU-induced cell death in HCT116 colorectal cancer cells [J]. Anticancer Res, 2018, 38(1):271-277.
[17]
Zhang X, Chen Y, Hao L, et al. Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine [J]. Cancer Lett, 2016, 381(2):305-313.
[18]
Han D, Gao X, Wang M, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 [J]. Oncotarget, 2016, 7(16):22159-22173.
[1] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[2] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[3] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 唐亦骁, 陈峻, 连正星, 胡海涛, 鲁迪, 徐骁, 卫强. 白果内酯对小鼠肝缺血再灌注损伤保护作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 278-282.
[6] 胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[7] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[8] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[11] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[12] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[13] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[14] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[15] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?